5-FU chemotherapy linked to rare brain toxicity in cancer patient
“The patient’s symptoms resolved after permanently stopping 5-FU and administering lactulose and intravenous fluids, therefore supporting the diagnosis of hyperammonemic encephalopathy due to 5-FU.”
2026-02-05
(Press-News.org)
“The patient’s symptoms resolved after permanently stopping 5-FU and administering lactulose and intravenous fluids, therefore supporting the diagnosis of hyperammonemic encephalopathy due to 5-FU.”
BUFFALO, NY — February 5, 2026 — A new case report was published in Volume 12 of Oncoscience on December 23, 2025, titled “Silent toxicity: A rare case of 5-fluorouracil-induced hyperammonemic encephalopathy.”
In this report, Areti Kalfoutzou from the National and Kapodistrian University of Athens and colleagues describe a rare and potentially life-threatening complication called hyperammonemic encephalopathy, which is linked to the widely used chemotherapy drug 5-fluorouracil (5-FU). The case highlights the importance of monitoring neurological symptoms in patients receiving 5-FU, even when liver function appears normal.
Hyperammonemic encephalopathy is a serious condition caused by elevated levels of ammonia in the blood, leading to acute confusion, reduced consciousness, and other neurocognitive disturbances. The case involves a 63-year-old woman with a history of pancreatic cancer who had undergone multiple surgeries and chemotherapy. Following several cycles of a regimen that included 5-FU, she developed repeated episodes of confusion and lethargy. Despite normal liver function, laboratory tests revealed significantly elevated serum ammonia levels.
“Her past medical history included epileptic seizures, diabetes mellitus and hypothyroidism.”
Upon discontinuation of 5-FU and administration of standard treatments for hyperammonemia, including lactulose and intravenous fluids, the patient’s neurological symptoms resolved rapidly. The improvement strongly supported the diagnosis. Using the Naranjo adverse drug reaction probability scale, the authors identified 5-FU as the most likely cause of the toxicity.
The researchers also considered other medications the patient was taking, including antiepileptic drugs and irinotecan, which have also been associated with hyperammonemia. However, the pattern of symptom recurrence following each 5-FU infusion, and resolution after discontinuation, reinforced its role as the primary trigger.
Although 5-FU is commonly used to treat gastrointestinal and other solid tumors, it may affect ammonia clearance by disrupting energy metabolism and liver detoxification pathways. When ammonia accumulates in the bloodstream, it can cross the blood-brain barrier and cause neurotoxic effects, even in patients without liver impairment.
This case reinforces the need for clinicians to be vigilant when treating cancer patients with 5-FU. Early recognition of altered mental status and immediate testing of serum ammonia levels can lead to timely intervention, preventing serious outcomes. The authors advise careful consideration before reintroducing 5-FU and recommend doing so only in close collaboration with specialists in metabolic or drug-related toxicities.
DOI: https://doi.org/10.18632/oncoscience.638
Correspondence to: Areti Kalfoutzou – areti.kalfoutzou@haf.gr
Abstract video: https://www.youtube.com/watch?v=30iB3ZmCvJA
Keywords: oncology, hyperammonemia, encephalopathy, fluorouracil, neurotoxicity
Click here to sign up for free Altmetric alerts about this article.
About Oncoscience:
Oncoscience is a peer-reviewed, open-access, traditional journal covering the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. This journal has a special mission: freeing oncology from publication costs. It is free to readers and authors.
Oncoscience is indexed and archived by PubMed, PubMed Central, Scopus, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
To learn more about Oncoscience, visit Oncoscience.us and connect with us on social media:
X
Instagram
Facebook
YouTube
LinkedIn
For media inquiries, please contact media@impactjournals.com.
END
ELSE PRESS RELEASES FROM THIS DATE:
2026-02-05
(Toronto, February 5, 2026) JMIR Publications, a leader in open access scholarly publishing, today announced the launch of the new Karma Reviewer Rewards Program. This initiative introduces a specialized, merit-based framework designed to elevate and reward the critical role of peer reviewers in the scientific process.
The evolved Karma program marks a strategic shift toward a quality-focused reward model. Moving away from traditional volume-based incentives, the new system ensures that rewards ...
2026-02-05
More than 50 skuas in Antarctica died from the high pathogenicity avian influenza virus H5N1 in the summers of 2023 and 2024, marking the first documented die-off of wildlife from the virus on the continent. That is confirmed for the first time in a study led by Erasmus MC in The Netherlands and the University of California, Davis. It published this week in the Nature journal Scientific Reports.
A relative of gulls, skuas are predatory, large brown birds living mostly in polar and subpolar environments. Similar ...
2026-02-05
New research suggests the liver plays a previously unrecognized role in bone health, but only in males.
A McGill University-led study published in Matrix Biology found that a protein made in the liver helps regulate bone growth in male mice, but not in females. The findings may help explain why men with liver disease are more likely to experience bone loss.
The protein, known as plasma fibronectin, is naturally present in blood at higher levels in men than in women, declines when the liver is damaged and builds up in bone to modulate bone formation. This suggests men rely more heavily on the protein to maintain bone strength than do women.
“About ...
2026-02-05
Next month, thousands of scientists from around the world will convene to share new research results from across physics at the American Physical Society’s Global Physics Summit. The conference will be held in Denver and online everywhere March 15-20.
Press registration
News media with valid APS press credentials may register for the meeting at no cost. To request press credentials, visit APS’ online newsroom. Registration will remain open throughout the meeting.
Housing information
Discounted hotel rates are available for in-person attendees at select hotels near the Colorado ...
2026-02-05
Tooling up to diagnose ocean health
Field-deployable CRISPR-based biosensing platform could enable facile, real-time monitoring of marine barometer species and ecosystems
By Benjamin Boettner
(BOSTON) — Oceanic ecosystems are increasingly threatened by global warming which causes coral bleaching, species migration and, through the loss of habitats and biodiversity, food web disruptions on major scales. Also, pollutants such as plastics and other marine debris, wastewater, as well as chemical runoffs, including oil spills, cause major ecosystem disruptions. Importantly, given the interconnectedness of all life on the planet, the deteriorating health of our ...
2026-02-05
FERNANDINA BEACH, Fla., February 3, 2026 — To kick off Super Bowl LX week and American Heart Month, the Family Heart Foundation, a leading research and advocacy organization, is teaming up with three-time Pro Bowler and former Seattle NFL quarterback Matt Hasselbeck to launch a national campaign focused on raising awareness of high cholesterol as a key risk factor for heart attack and stroke. The campaign, “Tackle Cholesterol: Get into the LDL Safe Zone,” reinforces the importance of early ...
2026-02-05
A peer reviewed, randomized controlled study with 199 women living in poverty in the city slums of Uganda was published today in Health Care for Women International. This study was conducted following two extended country-wide lockdowns in Uganda during the Covid 19 pandemic. Researchers found that the Transcendental Meditation® (TM®) technique reduced perceived stress, anger, and fatigue; increased self-efficacy; and improved sleep quality. TM helped these women to improve their mental and physical health and positively impacted their ability to cope in this crisis.
“The Covid lockdowns in Uganda, which resulted in food shortages, lack of employment, ...
2026-02-05
For decades, gynecological tests have relied on a simplified view of the vaginal microbiome, categorizing bacteria as either “good” or “bad.” New research from University of Maryland School of Medicine scientists challenges that assumption, revealing that bacteria of the same species can behave in fundamentally different ways, with important implications for women’s health.
Today, gynecological tests largely focus on detecting two groups of bacteria in the vaginal microbiome: Lactobacillus, generally associated with health, and Gardnerella, which has been linked to Bacterial Vaginosis (BV), increased risk of sexually transmitted diseases, ...
2026-02-05
CLEVELAND— More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS).
The drugs are effective but don’t eliminate the virus; HIV remains hidden in “reservoirs” throughout the body, ready to reactivate if treatment stops.
But researchers at Case Western Reserve University, in collaboration with the University of Pittsburgh, have made a significant breakthrough in HIV treatment. They’ve ...
2026-02-05
LOS ANGELES — Parkinson’s disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year. Although available treatments can help manage symptoms, there is currently no cure or therapy proven to slow the progression of the disease.
Parkinson’s disease is associated with reduced dopamine release in the brain. Dopamine is a neurotransmitter essential for movement, memory, mood and ...
LAST 30 PRESS RELEASES:
[Press-News.org] 5-FU chemotherapy linked to rare brain toxicity in cancer patient
“The patient’s symptoms resolved after permanently stopping 5-FU and administering lactulose and intravenous fluids, therefore supporting the diagnosis of hyperammonemic encephalopathy due to 5-FU.”
